This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Pathogenesis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The basic defect in Hashimoto's disease appears to be a deficiency of antigen-specific suppressor T cells. This permits uncontrolled attack on the follicular cells by cytotoxic T cells with simultaneous unregulated T helper cell participation in the formation of autoantibodies by B-cells.

The autoantibodies most consistently found in Hashimoto's disease are to the TSH receptor and to thyroid microsomes. Those to the TSH receptor are thyroid growth stimulating immunoglobulins. Less commonly, there are autoantibodies to thyroglobulin and to follicular cell membranes.

Thyroid enlargement probably reflects:

  • thyroid growth without increased hormone synthesis
  • lymphocytic infiltration
  • occasionally, increased TSH levels

The thyroglobulin and thyroid microsomal antibodies are probably secondary to follicular cell damage initiated by cytotoxic T cells.

The association with the HLA-DR5 genotype may indicate a genetic predisposition to this pattern of autoantibody production.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.